BrightEdge

Type

Accelerator/Incubator, CVC

Status

Active

Location

Atlanta, United States

Total investments

20

Average round size

36M

Portfolio companies

16

Rounds per year

3.33

Lead investments

1

Follow on index

0.20

Exits

2

Stages of investment
Early Stage Venture
Areas of investment
BiotechnologyFinTechFitnessHealth CareHealth DiagnosticsWellnessMedical DeviceMedicalPharmaceuticalTherapeutics

Summary

The leading representative office of defined VC is situated in the Atlanta. The venture was found in North America in United States. BrightEdge Fund appeared to be a CVC structure as part of the corporation.

The typical case for the fund is to invest in rounds with 6-7 participants. Despite the BrightEdge Fund, startups are often financed by Lilly Asia Ventures, Founders Fund, Data Collective DCVC. The meaningful sponsors for the fund in investment in the same round are Andreessen Horowitz, Westlake Village BioPartners, Verily.

For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. We can highlight the next thriving fund investment areas, such as Personal Health, Health Care. The fund has no exact preference in some founders of portfolio startups. If startup sums 2 or 5+ of the founder, the chance for it to be financed is low. Besides, a startup needs to be aged 6-10 years to get the investment from the fund. Among the most popular portfolio startups of the fund, we may highlight Freenome, Navigating Cancer, Castle Biosciences.

Speaking about the real fund results, this VC is 13 percentage points more often commits exit comparing to other organizations. The top amount of exits for fund were in 2019. The usual things for fund are deals in the range of 50 - 100 millions dollars. The top activity for fund was in 2019. The fund is constantly included in 2-6 deals per year. Comparing to the other companies, this BrightEdge Fund performs on 4 percentage points more the average number of lead investments.

Show more

Investor highlights

Industry focus
MedtechHealthcare
Stage focus
Series ASeries B

Discover reliable insights

Find relevant VC investors, identify key contacts and secure funding opportunities.

Investments analytics

Analytics

Total investments
20
Lead investments
1
Exits
2
Rounds per year
3.33
Follow on index
0.20
Investments by industry
  • Biotechnology (13)
  • Health Care (12)
  • Therapeutics (8)
  • Medical (5)
  • Health Diagnostics (4)
  • Show 16 more
Investments by region
  • United States (16)
  • Israel (1)
  • United Kingdom (1)
Peak activity year
2022

Discover reliable insights

Leverage validated data, identify key contacts and secure funding opportunities for your business.

Quantitative data

Avg. startup age at the time of investment
6
Group Appearance index
0.95

Need more data?

Get access to full data about investors, including their team, contact information, and historic data.

Latest deals

Company name Deal date Industry Deal stage Deal size Location
Clasp Therapeutics 20 Mar 2024 Early Stage Venture 150M United States, Massachusetts, Cambridge
Persephone Biosciences 19 Jul 2022 Biotechnology, Artificial Intelligence, Health Care, Medical Seed 15M United States, California, San Diego

Similar funds

By same location

By same geo focus

By doing lead investments

How we get our data

At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).

Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.